Virtu Financial LLC

Position in ATYR — aTYR PHARMA INC

CIK 1533964 New York, NY

Position in ATYR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$28,011

-$3,226 QoQ

Shares Held

46,921

+17.2% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 90 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $37,870,510 across 148 Biotechnology names. ATYR ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	58,459	$4,130,128
2	APGE	Apogee Therapeutics, Inc.	29,790	$3,954,026
3	ABVX	Abivax S.A.	19,155	$2,552,595
4	AXSM	Axsome Therapeutics, Inc.	9,220	$2,256,779
5	KYMR	Kymera Therapeutics, Inc.	12,556	$1,439,796
6	PTGX	Protagonist Therapeutics, Inc	8,163	$1,000,620
7	TGTX	Tg Therapeutics, Inc.	17,524	$962,768
8	IOVA	Iovance Biotherapeutics, Inc.	221,500	$921,440

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,011	46,921	+17.2%	Shares	Defined	2026-08-13
2026-03-31	$31,237	40,048	-49.3%	Shares	Defined	2026-05-14
2025-12-31	$61,820	78,953	+147.0%	Shares	Defined	2026-02-23
2025-06-30	$162,032	31,959	+10.1%	Shares	Defined	2025-08-12
2024-09-30	$51,069	29,017	+3.8%	Shares	Defined	2024-11-20
2024-06-30	$43,626	27,966	+5.9%	Shares	Defined	2024-08-09
2023-12-31	$37,236	26,409	+93.3%	Shares	Defined	2024-02-26
2023-09-30	$21,585	13,662	+6.4%	Shares	Defined	2023-11-15
2022-06-30	$36,351	12,845	-2.1%	Shares	Defined	2022-08-09
2022-03-31	$70,224	13,126	-90.9%	Shares	Defined	2022-05-17
2021-09-30	$1,304,587	143,677	+418.0%	Shares	Defined	2021-11-12
2020-12-31	$107,615	27,736	—	Shares	Defined	2021-02-24
No filing history on record for this holder in this stock.